Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines
暂无分享,去创建一个
A. Smith | J. Bramson | J Bramson | K Dayball | C Evelegh | Y H Wan | D Page | A Smith | C. Evelegh | K. Dayball | Y. Wan | D. Page | A. Smith | Kelley Dayball | Carole Evelegh | Yonghong Wan
[1] T. Tüting,et al. Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4+ T cell-dependent mechanism , 2001, Gene Therapy.
[2] Y. Kawaoka,et al. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice , 2000, Nature Medicine.
[3] Jonathan J. Lewis,et al. Coupling and Uncoupling of Tumor Immunity and Autoimmunity , 1999, The Journal of experimental medicine.
[4] D. Pardoll,et al. Inducing autoimmune disease to treat cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Tang,et al. Vaccination onto bare skin , 1997, Nature.
[6] B. Spellberg. The cutaneous citadel: a holistic view of skin and immunity. , 2000, Life sciences.
[7] J. Kaplan,et al. Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] B. W. Barry,et al. Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] J. Gauldie,et al. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination , 1997, Gene Therapy.
[10] B. Moss,et al. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] V. Schirrmacher,et al. Superiority of the ear pinna over muscle tissue as site for DNA vaccination , 1998, Gene Therapy.
[12] F. Graham,et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. , 1997, Human gene therapy.
[13] G. Matyas,et al. Skin immunization made possible by cholera toxin , 1998, Nature.
[14] A Smith,et al. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. , 1999, Diabetes technology & therapeutics.
[15] E. Hirschowitz,et al. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma , 1998, Gene Therapy.
[16] S. Rosenberg,et al. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. , 1996, Journal of immunology.
[17] M. Hitt,et al. Human adenovirus vectors for gene transfer into mammalian cells. , 1997, Advances in pharmacology.
[18] J. Gauldie,et al. Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines. , 2000, Cancer research.
[19] A. Enk,et al. Genetic immunization of mice with human tyrosinase‐related protein 2: Implications for the immunotherapy of melanoma , 2000, International journal of cancer.
[20] F. Graham,et al. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. , 1996, Human gene therapy.
[21] P. Khavari,et al. Immunization via hair follicles by topical application of naked DNA to normal skin , 1999, Nature Biotechnology.
[22] Y. Girerd-Chambaz,et al. Intradermal DNA immunization by using jet-injectors in mice and monkeys. , 1999, Vaccine.
[23] J. Bramson,et al. The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen , 2002, Expert opinion on biological therapy.
[24] C. Elmets,et al. Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines , 2001, Journal of Virology.
[25] P. Upadhyay,et al. Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. , 1999, Vaccine.
[26] Ajay K. Banga,et al. Electrically Assisted Transdermal And Topical Drug Delivery , 1998 .
[27] F. Graham,et al. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. , 2000, Human gene therapy.
[28] M. Allen,et al. Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.
[29] S. Rosenberg,et al. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. , 1996, Journal of immunology.
[30] C. Alving,et al. Transcutaneous immunization: A human vaccine delivery strategy using a patch , 2000, Nature Medicine.
[31] Dexiang Chen,et al. Epidermal Powder Immunization Induces both Cytotoxic T-Lymphocyte and Antibody Responses to Protein Antigens of Influenza and Hepatitis B Viruses , 2001, Journal of Virology.